GLP-1 vs traditional weight loss methods: which actually works?

Anyone who has tried to lose weight in South Africa knows the menu of options. Banting. Intermittent fasting. The gym. Weight Watchers. Garcinia. Phentermine. Bariatric surgery for the desperate. And now, GLP-1 therapy.

Most articles comparing these treat them as competing brands. They are not. They are tools that work at different parts of the problem, with very different success rates, costs, and risks. The question is not which is best in the abstract, it is which makes sense for your situation.

Diet and exercise alone

This is the starting point everyone is told to try first, and for good reason. It costs nothing, it carries no medical risk beyond overdoing it in the gym, and when it works it works permanently.

The honest truth from decades of clinical research is that diet and exercise alone produce 2 to 5 percent body weight loss on average, and most people regain that within two years. For someone weighing 100 kg, that is 2 to 5 kg of loss, often gained back. This is not because the advice is wrong. It is because the human body is biologically wired to defend its previous weight, and willpower against biology is a long-term losing strategy for most people.

That said, diet and exercise are not optional even when you add medication. They are what makes the loss sustainable. The two interventions that matter most are getting enough protein, around 1.2 to 1.6 grams per kilogram of body weight per day, and doing some form of resistance training twice a week. Cardio is good for your heart but does almost nothing for sustained weight loss on its own.

The patients who succeed long-term are not those who picked the perfect intervention. They are the ones who paired the right tool with the right habits.

Commercial meal plans and group programmes

Weight Watchers, Sleekgeek, banting groups, various influencer programmes. These work by giving you a framework to follow, social accountability, and a sense of community. The clinical literature on these programmes is reasonably positive in the short term, with average loss of 3 to 7 percent body weight in the first year for people who actually stick with them.

The catch is the sticking part. Adherence rates after twelve months are usually below 30 percent. The programmes themselves work. Most people stop following them. The reasons are predictable: it requires constant attention to food choices, it does not address underlying hunger biology, and life eventually gets in the way.

Where these programmes shine is as a habit-building layer alongside other interventions. Many patients use the principles from a programme like Sleekgeek to inform their eating during GLP-1 therapy. The structure helps. The structure alone usually is not enough.

Older appetite suppressants

Before GLP-1 therapy became available in South Africa, prescription appetite suppressants were the medical option for weight loss. These medications work by stimulating the central nervous system, which reduces hunger but also affects sleep, mood, and cardiovascular function.

The clinical results are modest. Average loss is around 3 to 7 percent body weight over six months. The side effect profile includes insomnia, anxiety, raised blood pressure, and constipation. They are typically prescribed for a maximum of three months at a time because of the risk of dependence.

For some patients these older medications still have a role, particularly when GLP-1 is not appropriate or affordable. But they are no longer the first choice for most clinicians, simply because the newer treatments are more effective and have a cleaner safety profile.

Bariatric surgery

Surgery is the most effective weight loss intervention available. Gastric bypass and gastric sleeve procedures produce 25 to 35 percent body weight loss on average, sustained over five years and beyond. For someone with severe obesity, particularly with related health conditions, surgery can be life-changing and sometimes life-saving.

The trade-offs are significant. Surgery is invasive, requires hospital admission, carries genuine surgical risk including a small mortality risk, and involves a lifelong adjustment to how you eat. Vitamin deficiencies become a permanent concern. Eating large meals becomes physically impossible. Some patients experience dumping syndrome, where eating sugar causes rapid, uncomfortable physiological reactions.

In South Africa, bariatric surgery costs between R80,000 and R200,000 in the private sector, depending on the procedure and facility. Some medical aids cover it with strict pre-authorisation, usually requiring documented evidence of failed lifestyle attempts and a BMI above 40, or above 35 with serious comorbidities.

Surgery makes sense for patients with severe obesity who have tried other approaches and have weight-related health conditions putting them at serious risk. It is a sledgehammer, appropriate when nothing smaller will move the wall.

Where GLP-1 fits

GLP-1 therapy sits between the lifestyle interventions and surgery. It is more effective than diet and exercise alone, less invasive than surgery, more clinically proven than older medications.

Average weight loss is 5 to 20 percent of body weight over twelve months. For most patients that lands in the 10 to 15 percent range, which translates to 10 to 18 kg of loss for someone starting at 100 kg. This is enough to substantially improve weight-related conditions like type 2 diabetes, sleep apnoea, and joint pain. It is enough to drop two or three clothing sizes. It is enough to make a real difference in how patients feel and move.

The mechanism is different from older medications. Instead of stimulating the nervous system to suppress appetite, GLP-1 therapy works with the body's natural fullness signals, making them stronger and more consistent. Side effects are usually mild and settle within a few weeks. There is no dependence risk.

The cost is the main barrier for many patients. Medication alone runs between R2500 and R3500 per month at therapeutic doses, plus consultation and lab fees. Over twelve months, the total programme cost typically lands between R35,000 and R45,000. Less than surgery, much more than lifestyle alone.

Which is right for you

If your BMI is below 27, the right answer is almost always lifestyle intervention with proper support. Medication is not appropriate at that level. A dietitian, a gym, or a structured programme will produce better outcomes for less money and less risk.

If your BMI is between 27 and 30 with a weight-related condition, GLP-1 therapy becomes an option, particularly if you have tried lifestyle change without lasting success. The treatment is well-suited to this group.

If your BMI is between 30 and 40, GLP-1 therapy is usually the first medical intervention to consider. The risk-benefit calculation strongly favours it over surgery at this stage, unless you have severe weight-related health conditions that surgery would resolve more quickly.

If your BMI is above 40, or above 35 with serious complications like uncontrolled type 2 diabetes or severe sleep apnoea, the conversation expands to include surgery. Some patients in this group use GLP-1 therapy as a bridge to surgery, losing enough weight to reduce surgical risk. Others use it instead of surgery if they want a less invasive route.

The honest answer is that there is no universal best option. Your situation matters. Your goals matter. Your tolerance for medication or surgery matters. A doctor who listens to all of that before recommending anything is doing the job properly.

The bottom line

GLP-1 therapy is not better than diet and exercise. It is different. It works for people whose biology has made conventional weight loss extremely difficult, by changing the biological signals that drive hunger and fullness. Used responsibly, with good clinical support, it produces results in months that have not been achievable in years of lifestyle attempts.

It is also not a substitute for the habits that make weight loss sustainable. The medication carries you. The habits keep you there once the medication stops.